Specialist pharma company Mallinckrodt announced on 26 December that it is to acquire Sucampo Pharmaceuticals for around $1.2 billion. The company’s management are clearly looking to bring cheer ...

Endo Inc. approved more than $3.5 million in retention bonuses for key executives, and that figure could grow, as it works to ...

Malvern-based Endo has approved $3.5 million in retention bonuses for its key executives as it works toward a merger with ...

Ireland’s Mallinckrodt will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion. The companies said Thursday that Endo shareholders will receive a total of $80 million in ...

Ireland's Mallinckrodt has agreed a $1.3 billion deal to acquire Therakos, gaining rights to a technology that underpins cell-based immunotherapies. Therakos' platform is based on extracorporeal ...

(RTTNews) - Specialty pharmaceutical companies Mallinckrodt plc and Endo, Inc. announced Thursday that they have entered into a definitive agreement to combine in a stock and cash transaction.

Five presentations highlight TERLIVAZ research in adults with HRS with rapid reduction in kidney function,1 also known as HRS-AKI<sup ...

DUBLIN, April 10, 2025 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced that it will report its first quarter 2025 financial results on Tuesday ...

Opioid settlements with companies like Purdue Pharma, Walmart, and Johnson & Johnson have led to headline-grabbing ...

Endo and Mallinckrodt, two drugmakers seeking to recover from opioid lawsuits and bankruptcies, are betting a combination will help. Investors took a dim view Thursday. Shares of Endo fell more ...

Jonathan Randles covers bankruptcy and corporate restructuring for WSJ Pro and The Wall Street Journal.